Clinical Trial: Early Ambulation Safety Evaluation, Ultrasound-guided Percutaneous Venous Closure

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07910227) titled 'Early Ambulation Safety Evaluation, Ultrasound-guided Percutaneous Venous Closure' on Oct. 26.

Brief Summary: The purpose of this study is to evaluate whether patients can safely walk sooner after catheter-based heart procedures when the VASCADE MVP or VASCADE MVP XL vascular closure device is used. Patients usually rest in bed for 2-4 hours before walking. The first group in this study will attempt to walk after about 90 minutes. If safety results allow, later participants may attempt to walk after about 60 minutes.

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: Catheter Ablation, Radiofrequency

Intervention: ...